Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis

G Vilahur, V Fuster - European Heart Journal, 2025 - academic.oup.com
Haemostasis refers to the physiological process aimed at repairing vessel injury and
preventing bleeding. It involves four interlinked stages culminating in the formation of a …

Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy

M Yan, Z Wang, Z Qiu, Y Cui, Q **ang - Biomarker Research, 2024 - Springer
Platelets are essential for blood clotting and maintaining normal hemostasis. In pathological
conditions, platelets are increasingly recognized as crucial regulatory factors in various …

The quest for the holy grail in antithrombotic therapy: revitalized hope for platelet GPVI as a safe and effective antithrombotic target

JD McFadyen, X Wang, K Peter - European Heart Journal, 2024 - academic.oup.com
Collagen binds to the platelet GPVI receptor and triggers platelet activation via the Fc
receptor γ (FcRγ) chain which contains an immunoreceptor tyrosine-based activation motif …

Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and Targets

D Schwarz, M Le Marois, V Sturm, AS Peters… - Diabetes, 2025 - diabetesjournals.org
Lesioned fascicles (LFs) in the sciatic nerves of individuals with diabetic neuropathy (DN)
correlate with clinical symptom severity. This study aimed to characterize the structural and …

Tracking GP VI in Abdominal Aortic Aneurysms: A Crucial Pathological Link?

E Mammadova-Bach, A Braun - Arteriosclerosis, Thrombosis, and …, 2024 - ahajournals.org
AAAs are vascular disorders characterized by the dilation of the abdominal aorta, associated
with high morbidity. 2 The destruction of the medial layer of the aorta causes irreversible …

PROTACs in platelets: emerging antithrombotic strategies and future perspectives

JS Trory, J Vautrinot, CJ May, I Hers - Current Opinion in …, 2025 - journals.lww.com
Platelets are susceptible to targeted protein degradation by CRBN ligand-based PROTACs
and have limited ability to resynthesise proteins, ensuring long-term downregulation of …

A GPVI-platelet-neutrophil-NET axis drives systemic sclerosis

R Darbousset, L Senkpeil, J Kuehn, S Balu, D Miglani… - bioRxiv, 2025 - biorxiv.org
Systemic sclerosis (SSc) is characterized by progressive fibrosis of skin, lung, and other
organs and retains among the highest rates of mortality among autoimmune diseases. We …

Targeting an Olfactory Receptor Mitigates High Residual Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Depolymerization

A Aggarwal, VP Josyula, N Wang, M Yang, YJ Shim… - bioRxiv, 2024 - biorxiv.org
Background: Despite antiplatelet therapy, some patients remain at high risk for ischemic
events due to medication non-responsiveness or High Residual Platelet Reactivity (HRPR) …

[PDF][PDF] Contrasting Effects of Platelet GPVI Deletion versus Syk Inhibition on Mouse Jugular Vein Puncture Wound Structure

ID Pokrovskaya, KK Ball, MW Webb, SW Rhee, J Ware… - 2025 - preprints.org
Platelet glycoprotein (GP) VI is a transmembrane protein that was originally characterized as
a collagen receptor supporting platelet adhesion and activation through its association with …